Brighter Side of News
HomeGood NewsDiscoveriesInnovationsGlobal GoodHealthGreen ImpactSpaceAICelebritiesGNISubscribe

Clinical trials

HealthFDA approves once-daily Parkinson’s pill (Juvmo) built on decades of work by husband-and-wife team

Once-daily tavapadon offers a new Parkinson’s treatment option, with symptom benefits supported by trials and important safety limits.

Mac Oliveau
Health$101 million XPRIZE Healthspan competition advances 20 teams to finals with UCSD named as testing hubJoseph Shavit
HealthNew blood test predicts when Alzheimer’s symptoms will beginMac Oliveau
Brighter Side of News
  • Explore
  • About Us
  • News Feed
  • Sitemap
  • Editorial Guidelines
  • Legal
  • Privacy
  • Terms
  • Read More
  • Newsletter Sign-up
  • Flipboard